{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,4]],"date-time":"2026-10-04T09:57:52Z","timestamp":1791107872266,"version":"4.1.0"},"reference-count":30,"publisher":"Elsevier BV","issue":"8","license":[{"start":{"date-parts":[[2010,10,1]],"date-time":"2010-10-01T00:00:00Z","timestamp":1285891200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Biochemical Pharmacology"],"published-print":{"date-parts":[[2010,10]]},"DOI":"10.1016\/j.bcp.2010.06.045","type":"journal-article","created":{"date-parts":[[2010,7,7]],"date-time":"2010-07-07T08:36:28Z","timestamp":1278491788000},"page":"1252-1259","source":"Crossref","is-referenced-by-count":59,"title":["Main contribution of the cytochrome P450 isoenzyme 1A2 (CYP1A2) to N-demethylation and 5-sulfoxidation of the phenothiazine neuroleptic chlorpromazine in human liver\u2014A comparison with other phenothiazines"],"prefix":"10.1016","volume":"80","author":[{"given":"Jacek","family":"W\u00f3jcikowski","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jan","family":"Boksa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"W\u0142adys\u0142awa A.","family":"Daniel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bcp.2010.06.045_bib0005","first-page":"CD007778","article-title":"Chlorpromazine dose for people with schizophrenia","volume":"2","author":"Liu","year":"2009","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.bcp.2010.06.045_bib0010","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/S0022-3565(25)32494-8","article-title":"Interactions of neuroleptic metabolites with dopaminergic, alpha adrenergic and muscarinic cholinergic receptors","volume":"217","author":"Bylund","year":"1981","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.bcp.2010.06.045_bib0015","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1016\/0014-2999(86)90793-4","article-title":"Phenothiazine drugs metabolites: dopamine D2 receptor, \u03b11 and \u03b12-adrenoceptor binding","volume":"125","author":"Hals","year":"1986","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.bcp.2010.06.045_bib0020","doi-asserted-by":"crossref","first-page":"277","DOI":"10.3109\/00498258809041664","article-title":"Correlation of activity of chlorpromazine and respective hydroxy, dimethoxy and sulphoxide analogues on dopamine, muscarinic, histamine and calmoduline sites of action","volume":"18","author":"Palmer","year":"1988","journal-title":"Xenobiotica"},{"key":"10.1016\/j.bcp.2010.06.045_bib0025","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1016\/S0090-9556(25)08012-2","article-title":"Chlorpromazine metabolism in extracts of liver and small intestine from guinea pig and from man","volume":"3","author":"Hartmann","year":"1983","journal-title":"Drug Metab Dispos"},{"key":"10.1016\/j.bcp.2010.06.045_bib0030","series-title":"Progress in drug metabolism","first-page":"111","article-title":"Metabolism and pharmacokinetics of antypsychotic drugs","author":"J\u00f8rgensen","year":"1986"},{"key":"10.1016\/j.bcp.2010.06.045_bib0035","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1097\/00007691-198709000-00018","article-title":"Therapeutic monitoring of chlorpromazine. IV: comparison of new high-performance liquid chromatographic method with radioimmunoassays for parent drug and some of its major metabolites","volume":"3","author":"Midha","year":"1987","journal-title":"Ther Drug Monit"},{"key":"10.1016\/j.bcp.2010.06.045_bib0040","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1097\/00007691-199402000-00004","article-title":"Important metabolites to measure in pharmacodynamic studies of chlorpromazine","volume":"1","author":"Chetty","year":"1994","journal-title":"Ther Drug Monit"},{"key":"10.1016\/j.bcp.2010.06.045_bib0045","first-page":"367","article-title":"Metabolism of psychotropic drugs: pharmacological and clinical relevance","volume":"47","author":"Daniel","year":"1995","journal-title":"Pol J Pharmacol"},{"key":"10.1016\/j.bcp.2010.06.045_bib0050","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/0924-977X(95)00047-S","article-title":"Response in chronic schizophrenia correlated with chlorpromazine, 7-OH-chlorpromazine and chlorpromazine sulfoxide levels","volume":"2","author":"Chetty","year":"1996","journal-title":"Eur Neuropsychopharmacol"},{"key":"10.1016\/j.bcp.2010.06.045_bib0055","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/S0924-977X(98)00005-4","article-title":"The use of a side effects as a qualitative indicator of plasma chlorpromazine levels","volume":"1\u20132","author":"Chetty","year":"1999","journal-title":"Eur Neuropsychopharmacol"},{"key":"10.1016\/j.bcp.2010.06.045_bib0060","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/S0024-3205(00)00613-5","article-title":"Identification of human cytochrome P450 isoform involved in the 7-hydroxylation of chlorpromazine by human liver microsomes","volume":"67","author":"Yoshii","year":"2000","journal-title":"Life Sci"},{"key":"10.1016\/j.bcp.2010.06.045_bib0065","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1016\/S0090-9556(25)07406-9","article-title":"Stereo- and regioselective N- and S-oxidation of tertiary amines and sulfides in the presence of adult human liver microsomes","volume":"21","author":"Cashman","year":"1993","journal-title":"Drug Metab Dispos"},{"key":"10.1016\/j.bcp.2010.06.045_bib0070","doi-asserted-by":"crossref","first-page":"1297","DOI":"10.1016\/j.pnpbp.2007.05.013","article-title":"Functional polymorphism of the cytochrome P450 1A2 (CYP1A2) gene and prolonged QTc interval in schizophrenia","volume":"6","author":"Tay","year":"2007","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"key":"10.1016\/j.bcp.2010.06.045_bib0075","first-page":"523","article-title":"Smoking and body weight influence the clearance of chlorpromazine","volume":"6","author":"Chetty","year":"1994","journal-title":"Eur J Clin Pharmacol"},{"key":"10.1016\/j.bcp.2010.06.045_bib0080","doi-asserted-by":"crossref","first-page":"3249","DOI":"10.1016\/0006-2952(86)90420-X","article-title":"The effect of neuroleptics on imipramine demethylation in rat liver microsomes and imipramine and desipramine level in the rat brain","volume":"19","author":"Daniel","year":"1986","journal-title":"Biochem Pharmacol"},{"key":"10.1016\/j.bcp.2010.06.045_bib0085","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1016\/S0026-895X(25)13662-6","article-title":"Major pathway of imipramine metabolism is characterized by cytochrome P-450 1A2 and P-450 3A4 in human liver","volume":"43","author":"Lemoine","year":"1993","journal-title":"Mol Pharmacol"},{"key":"10.1016\/j.bcp.2010.06.045_bib0090","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1016\/S0022-3565(25)21837-7","article-title":"A study of the kinetics of chlorpromazine sulfoxide by a specific radioimmunoassay after a single oral dose of chlorpromazine in healthy volunteers","volume":"3","author":"Yeung","year":"1983","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.bcp.2010.06.045_bib0095","first-page":"465","article-title":"Integrated cytochrome P450 reaction phenotyping: attempting to bridge the gap between cDNA-expressed cytochromes P450 and native human liver microsomes","volume":"57","author":"Rodrigues","year":"1999","journal-title":"Biochem Prarmacol"},{"key":"10.1016\/j.bcp.2010.06.045_bib0100","doi-asserted-by":"crossref","first-page":"1381","DOI":"10.1016\/S0090-9556(24)14947-1","article-title":"Azelastine N-demethylation by cytochrome P-450 (CYP)3A4, CYP2D6, and CYP1A2 in human liver microsomes: evaluation of approach to predict the contribution of multiple CYPs","volume":"27","author":"Nakajima","year":"1999","journal-title":"Drug Metab Dispos"},{"key":"10.1016\/j.bcp.2010.06.045_bib0105","doi-asserted-by":"crossref","first-page":"1493","DOI":"10.1016\/S0090-9556(24)13680-X","article-title":"Comparison between cytochrome P450 (CYP) content and relative activity approaches to scaling from cDNA-expressed CYPs to human liver microsomes: ratios of accessory proteins as sources of discrepancies between the approaches","volume":"28","author":"Venkatakrishnan","year":"2000","journal-title":"Drug Metab Dispos"},{"key":"10.1016\/j.bcp.2010.06.045_bib0110","doi-asserted-by":"crossref","first-page":"1465","DOI":"10.1038\/sj.bjp.0705195","article-title":"Contribution of human cytochrome P-450 isoforms to the metabolism of the simplest phenothiazine neuroleptic promazine","volume":"138","author":"W\u00f3jcikowski","year":"2003","journal-title":"Br J Pharmacol"},{"key":"10.1016\/j.bcp.2010.06.045_bib0115","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/S0924-977X(03)00105-6","article-title":"The metabolism of the piperazine-type phenothiazine neuroleptic perazine by the human cytochrome P-450 isoenzymes","volume":"14","author":"W\u00f3jcikowski","year":"2004","journal-title":"Eur Neuropsychopharmacol"},{"key":"10.1016\/j.bcp.2010.06.045_bib0120","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1124\/dmd.105.006445","article-title":"Characterization of human cytochrome P450 enzymes involved in the metabolism of the piperidine-type phenothiazine neuroleptic thioridazine","volume":"3","author":"W\u00f3jcikowski","year":"2006","journal-title":"Drug Metab Dispos"},{"key":"10.1016\/j.bcp.2010.06.045_bib0125","doi-asserted-by":"crossref","first-page":"454","DOI":"10.2165\/00003088-198106060-00003","article-title":"Interaction of chlorpromazine and nortryptyline in patients with schizophrenia","volume":"6","author":"Loga","year":"1981","journal-title":"Clin Pharmacokinet"},{"issue":"Suppl. 9","key":"10.1016\/j.bcp.2010.06.045_bib0130","first-page":"42","article-title":"Combined treatment strategies in psychiatry","volume":"54","author":"Nelson","year":"1993","journal-title":"J Clin Psychiat"},{"key":"10.1016\/j.bcp.2010.06.045_bib0135","doi-asserted-by":"crossref","first-page":"698","DOI":"10.1016\/0006-3223(92)90279-9","article-title":"Fluvoxamine improves negative symptoms in treated chronic schizophrenia: an add-on double-blind, placebo-controlled study","volume":"31","author":"Silver","year":"1992","journal-title":"Biol Psychiat"},{"key":"10.1016\/j.bcp.2010.06.045_bib0140","doi-asserted-by":"crossref","first-page":"1211","DOI":"10.1016\/0006-2952(93)90272-X","article-title":"Fluvoxamine is a potent inhibitor of cytochrome P4501A2","volume":"45","author":"Br\u00f8sen","year":"1993","journal-title":"Biochem Pharmacol"},{"key":"10.1016\/j.bcp.2010.06.045_bib0145","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1016\/S0022-3565(25)22379-5","article-title":"Interindividual variations in human liver cytochrome P-450 enzymes involved in the oxidation of drugs, carcinogenes and toxic chemicals: studies with liver microsomes of 30 Japanese and 30 Caucasians","volume":"270","author":"Shimada","year":"1994","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.bcp.2010.06.045_bib0150","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1038\/nrd2173","article-title":"Simulation and prediction of in vivo drug metabolism in human populations from in vitro data","volume":"6","author":"Rostami-Hodjegan","year":"2007","journal-title":"Nat Rev Drug Discov"}],"container-title":["Biochemical Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S000629521000479X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S000629521000479X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,2,22]],"date-time":"2025-02-22T18:45:54Z","timestamp":1740249954000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S000629521000479X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,10]]},"references-count":30,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2010,10]]}},"alternative-id":["S000629521000479X"],"URL":"https:\/\/doi.org\/10.1016\/j.bcp.2010.06.045","relation":{},"ISSN":["0006-2952"],"issn-type":[{"value":"0006-2952","type":"print"}],"subject":[],"published":{"date-parts":[[2010,10]]}}}